Injective's INJ token was changing hands at $6.96 early Thursday, down 5.25% over the prior 24 hours, as digital assets sold off broadly after Federal Reserve meeting minutes pointed to a possible larger-than-expected rate increase in December.
Pricing data from CoinGecko taken at 03:55 UTC on Nov. 19 put the token at that level, while Binance's INJ/USDT market showed a session range running from a low of $6.814 to a high of $7.433. The move tracked a wider retreat in crypto rather than any company-specific disclosure.
Bitcoin, the largest digital asset, fell to $62,675.46, also a 5.25% drop over the same window, according to CoinGabbar's Nov. 19 market report. Total crypto market capitalization slipped 2.1% to $2.24 trillion.
The macro backdrop did the heavy lifting. Minutes from the Federal Open Market Committee's recent meeting, released Nov. 18-19, 2026, signaled that officials could raise rates by more than 25 basis points in December. Fed Governor Christopher Waller has publicly backed a potential 50 basis point increase. Higher borrowing costs tend to pressure speculative assets, and crypto has traded in sympathy with rate expectations through much of the cycle.
Sentiment gauges reflected the shift. The Crypto Fear and Greed Index, which scores market mood from 0 (maximum fear) to 100 (maximum greed), read 10 on Nov. 19, a reading labeled "Extreme Fear." A month earlier the same measure stood at 55.
Injective's home sector fared no better. The combined market value of DeFi tokens dropped 2% to $57.66 billion, and Bitcoin dominance, the share of total crypto value held by Bitcoin, sat at 56.6%.
Note: Price and range figures are timestamped 03:55 UTC on Nov. 19, 2026. Broader market figures are attributed to CoinGabbar's Nov. 19 market report.
Derivatives positioning leaned bearish. Binance's INJUSDT perpetual futures carried a funding rate of -0.0090% at the same timestamp, meaning traders holding short positions were paying those holding longs. The reading points to a short-heavy book on that venue, though it covers a single exchange and does not by itself explain spot price action.
What the data cannot do is establish why INJ specifically fell. The timing lines up with a market-wide risk-off session, and the token's decline matched Bitcoin's percentage move almost exactly, but correlation at a single timestamp is not causation. No Injective-specific announcement, protocol event or exchange notice accompanied the drop in the available record.
The session range offers a practical reference point. A move outside $6.814 to $7.433 would mark a fresh directional break, though a single breach would not confirm a change in momentum.
For traders, the combination of extreme fear readings, negative funding and a macro catalyst describes a defensive market rather than a token-specific problem. Injective's price remains tied to the broader risk appetite that Fed policy expectations are currently shaping, and the December meeting is the next scheduled event capable of resetting that appetite in either direction.
Once added, BigGo Finance appears first in Google Search Top Stories, so you get the broadest, most up-to-the-minute, and most comprehensive global financial news first.



